Policy / Regulatory

NMPA Publishes 110th Batch of Chemical Generic Drug Reference Listed Drug Catalog – 28 New Specifications Added

NMPA Publishes 110th Batch of Chemical Generic Drug Reference Listed Drug Catalog – 28 New Specifications Added

The National Medical Products Administration (NMPA) has released the 110th batch of the Catalog of Reference Listed Drugs (RLD) for Chemical Generic Drugs, adding 28 new drug specifications and providing…

NMPA Proposes Drug Market Exclusivity Framework – Up to Seven Years for Rare Disease Therapies and Two Years for Pediatric Drugs

NMPA Proposes Drug Market Exclusivity Framework – Up to Seven Years for Rare Disease Therapies and Two Years for Pediatric Drugs

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Guangdong Launches 5‑Year Plan to Streamline Import of Urgently Needed Drugs and Medical Devices
Greater Bay Area

Guangdong Launches 5‑Year Plan to Streamline Import of Urgently Needed Drugs and Medical Devices

NMPA Releases 96th Reference Listed Drugs Catalog, Adding 42 New Generic Specifications

NMPA Releases 96th Reference Listed Drugs Catalog, Adding 42 New Generic Specifications

FDA Launches Aggressive Campaign to Curb Misleading Drug Advertisements

FDA Launches Aggressive Campaign to Curb Misleading Drug Advertisements

NMPA Unveils 30‑Working‑Day Pathway to Accelerate Innovative Drug Trials
CDENMPA

NMPA Unveils 30‑Working‑Day Pathway to Accelerate Innovative Drug Trials

Show More